“It is an honor to have been selected to present data at the AAD from our two major clinical validation studies, which are two of our four studies serving as principal support for our FDA submission,” said DermaSensor’s CEO, Cody Simmons. “Having spent a decade miniaturizing and conducting studies with our spectroscopy technology, we hope to soon equip PCPs in the U.S. with our handheld, wireless device in order to improve their detection and referral of skin cancer, which is more common than all other cancers combined.”

SELUTION DeNovo compares the treatment strategy using a novel sirolimus drug-eluting balloon [DEB SELUTION], versus a limus drug-eluting stent [DES].

An AI tool that can accurately differentiate between normal and abnormal chest X-rays would greatly alleviate the heavy workload experienced by radiologists globally.

The study, “Patient Satisfaction and Outcomes following Outpatient Joint Arthroplasty in Academic Medical Centers,” presented at the 2023 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, also showed that patients had short discharge times and low readmission rates after outpatient total joint arthroplasty.

Dr. Hartwell and his colleagues conducted the prospective cohort study, “Does Running Increase the Risk for Hip and Knee Arthritis? A Survey of 3,804 Chicago Marathon Runners,” during his residency at Northwestern University Feinberg School of Medicine in Chicago.

In the study, “Trends in Complications and Outcomes in Patients Aged 65 and Younger Undergoing Total Hip Arthroplasty: Data from the American Joint Replacement Registry,” the team used the Registry’s database to identify all THA procedures performed from 2012 through 2020 in patients aged 18 to 65. Exclusion criteria included patients with revision and oncologic THA cases, conversion from prior surgery and non-elective cases. The study measured primary outcomes including cumulative revision rate, 90-day readmission rate and reason for revision. In total, 5,153 patients were included in the analysis (51% female and 49% male) with an average age of 56.7 years ± 7.8 years. Mean follow up was 39.57 months.